Skip to main content
  • Sections
  • Search

Center for Strategic & International Studies

User menu

  • Subscribe
  • Sign In

   Ranked #1 Think Tank in U.S. by Global Go To Think Tank Index

Topics

  • Climate Change
  • Cybersecurity and Technology
    • Cybersecurity
    • Data Governance
    • Intelligence, Surveillance, and Privacy
    • Military Technology
    • Space
    • Technology and Innovation
  • Defense and Security
    • Counterterrorism and Homeland Security
    • Defense Budget
    • Defense Industry, Acquisition, and Innovation
    • Defense Strategy and Capabilities
    • Geopolitics and International Security
    • Long-Term Futures
    • Missile Defense
    • Space
    • Weapons of Mass Destruction Proliferation
  • Economics
    • Asian Economics
    • Global Economic Governance
    • Trade and International Business
  • Energy and Sustainability
    • Energy, Climate Change, and Environmental Impacts
    • Energy and Geopolitics
    • Energy Innovation
    • Energy Markets, Trends, and Outlooks
  • Global Health
    • Family Planning, Maternal and Child Health, and Immunizations
    • Multilateral Institutions
    • Health and Security
    • Infectious Disease
  • Human Rights
    • Civil Society
    • Transitional Justice
    • Human Security
  • International Development
    • Food and Agriculture
    • Governance and Rule of Law
    • Humanitarian Assistance
    • Private Sector Development
    • U.S. Development Policy

Regions

  • Africa
    • North Africa
    • Sub-Saharan Africa
  • Americas
    • Caribbean
    • North America
    • South America
  • Arctic
  • Asia
    • Afghanistan
    • Australia, New Zealand & Pacific
    • China
    • India
    • Japan
    • Korea
    • Pakistan
    • Southeast Asia
  • Europe
    • European Union
    • NATO
    • Post-Soviet Europe
    • Turkey
  • Middle East
    • The Gulf
    • Egypt and the Levant
    • North Africa
  • Russia and Eurasia
    • The South Caucasus
    • Central Asia
    • Post-Soviet Europe
    • Russia

Sections menu

  • Programs
  • Experts
  • Events
  • Analysis
    • Blogs
    • Books
    • Commentary
    • Congressional Testimony
    • Critical Questions
    • Interactive Reports
    • Journals
    • Newsletter
    • Reports
    • Transcript
  • Podcasts
  • iDeas Lab
  • Transcripts
  • Web Projects

Main menu

  • About Us
  • Support CSIS
    • Securing Our Future
Blog Post - Smart Global Health
Share
  • LinkedIn
  • Facebook
  • Twitter
  • Email
  • Printfriendly.com

H1N1: Do We Know How Many People Have Been Infected?

November 18, 2009

Stephen Morrison and Phillip Nieburg of CSIS recently co-authored a piece on uncertainties surrounding the H1N1 vaccine supply and President Obama’s decision to declare H1N1 a national emergency. The post produced many questions about vaccines and highlighted much of the confusion surrounding the flurry of information from health experts, government agencies and various news outlets.

Comment from the blog:

Schools are closing, parents are terrified, and much of this is being fueled by the fact the quality of reporting on 24 hour news stations is alarmist and detached from reality. Interviews are being given to random opinionated individuals with an "MD" by their name in favor of credited public health and influenza experts.

Should we be concerned that we aren't even trying to effectively track this disease? What you're saying is that numerical projections are completely bogus so any number spewed out to the population, in the thousands or millions, is a shot in the dark and heavily subject to political manipulation and sensational media. If hospitals aren't even testing for H1N1 on a large scale, how does Thomas Frieden presume to make any estimation at all?

Meanwhile, the Obama Administration will cover its tracks by declaring a national emergency because they are fearful of being viewed as unresponsive in an increasingly treacherous political climate of declining public support and accusations of ineffectiveness.

Americans are just looking for honesty. What are the actual projections for this disease? How bad is it really? Should parents be pulling their children out of school in droves? Should we be investing in protective masks for our families? Beyond washing our hands and avoiding public places while sick, are there any other preventative measures U.S. citizens can take?

Response from Phillip Nieburg:

The commenter is correct about the sometimes unhelpful quality of media reporting about H1N1, including the comments of people with limited understanding of disease surveillance and of public health in general.

Regarding the decision of the Centers for Disease Control and Prevention (CDC) to stop trying to count every person infected with H1N1, influenza is a disease with a wide spectrum of severity, from mild “cold” symptoms that do not include fever to overwhelming pneumonia and death. Once the existence of an influenza epidemic has been confirmed, as it has in this situation, the goal of influenza surveillance shifts from counting every infected person to gathering information on the severity and impact of disease. These latter data can better help guide decisions about the subsequent public health response. At this point, since infected people in the U.S. may ultimately number in the tens of millions, and since many mildly infected people with mild disease will not seek medical attention, and since confirming an H1N1 diagnosis requires an expensive laboratory test, it no longer makes sense to try to count every person infected with H1N1.

However, although the CDC has stopped counting every individual H1N1 infection, it is keeping close track of – and is making publicly available on a weekly basis - a number of other measures of epidemic influenza severity in the United States: (1) visits to doctors for influenza-like illness; (2) total influenza-related hospitalizations; (3) the proportions of weekly deaths recorded as being from pneumonia and influenza; (4) state health department estimates of the magnitude of influenza activity within each state; (5) the numbers and proportions of influenza viruses identified in laboratories as H1N1 viruses; (6) any resistance of circulating H1N1 viruses to oseltamivir, the principal anti-viral drug being recommended for high risk people infected with H1N1; and (7) influenza-associated pediatric mortality. Each of these disease indices is updated weekly and can be found online.

Related Content

  • Pandemic H1N1 Influenza
  • H1N1 in the Americas: Transmission patterns, vaccine production plans, and popular responses
  • China's H1N1 Response and Public Opinion
  • H1N1 Influenza and the U.S. Response: Looking Back at 2009

 

Media Queries

Contact H. Andrew Schwartz
Chief Communications Officer
Tel: 202.775.3242

Contact Caleb Diamond
Media Relations Manager and Editorial Associate
Tel: 202.775.3173

More from this blog

Blog Post
U.S.-Japan Dialogue: Strengthening the Partnership on Global Health
By J. Stephen Morrison
In Smart Global Health
July 25, 2017
Blog Post
Yellow Fever in Brazil: The Latest Global Health Security Threat
In Smart Global Health
June 23, 2017
Blog Post
Brazil's Sistema Único da Saúde (SUS): Caught in the Cross Fire
By Katherine E. Bliss
In Smart Global Health
June 21, 2017
Blog Post
GPEI’s Funding Decline Among Tedros’ Top Challenges as WHO Director-General
By Nellie Bristol
In Smart Global Health
June 9, 2017
Blog Post
Achieving TB Milestones Through Last Mile Delivery in India
In Smart Global Health
May 25, 2017
Blog Post
Training the Informal Health Workforce in India
In Smart Global Health
May 22, 2017
Blog Post
What’s to Be Done to End the Opioid Epidemic?
In Smart Global Health
May 19, 2017
Blog Post
New Partnerships Needed after Ebola's Hard Lessons
By J. Stephen Morrison
In Smart Global Health
April 25, 2017

Related Content

Report
What Can the United States Do to Prevent Another Pandemic? Commit to Modernizing Influenza Vaccines
October 14, 2020
Commentary
A New Covid-19 Mantra? 'Nobody Is Safe until Everybody Is Fed'
By Chase Sova
December 4, 2020
Critical Questions
Universal Health Coverage and Primary Health Care within the Covid-19 Context
By Katherine E. Bliss
December 11, 2020
Commentary
Covid-19, Food Systems, and Wild Animals
October 21, 2020
Commentary
A Covid-19 Response Corps Can Help Stop the Pandemic
April 6, 2020
Commentary
Which Covid-19 Future Will We Choose?
By J. Stephen Morrison, Anna McCaffrey
April 1, 2020
Critical Questions
The Novel Coronavirus Outbreak
By J. Stephen Morrison, Jude Blanchette, Scott Kennedy, Stephanie Segal
January 28, 2020
Report
Ensuring Healthy Populations through a New Era of Global Immunization
By Nellie Bristol
December 20, 2019
Footer menu
  • Topics
  • Regions
  • Programs
  • Experts
  • Events
  • Analysis
  • Web Projects
  • Podcasts
  • iDeas Lab
  • Transcripts
  • About Us
  • Support Us
Contact CSIS
Email CSIS
Tel: 202.887.0200
Fax: 202.775.3199
Visit CSIS Headquarters
1616 Rhode Island Avenue, NW
Washington, DC 20036
Media Queries

Contact H. Andrew Schwartz
Chief Communications Officer
Tel: 202.775.3242

Contact Caleb Diamond
Media Relations Manager and Editorial Associate
Tel: 202.775.3173

Daily Updates

Sign up to receive The Evening, a daily brief on the news, events, and people shaping the world of international affairs.

Subscribe to CSIS Newsletters

Follow CSIS
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

All content © 2020. All rights reserved.

Legal menu
  • Credits
  • Privacy Policy
  • Reprint Permissions